Candidiasis, infections caused by Candida spp., represents one of the most common nosocomial infections afflicting an expanding number of compromised patients. Antifungal therapeutic options are few and show limited efficacy. Moreover, biofilm formation is frequently associated with different manifestations of candidiasis and further complicates therapy. Thus, there is an urgent need for new effective therapeutic agents, particularly those with anti-biofilm activity. Here we describe the development of a novel, simple, fast, economical, and highly reproducible 384-well microtiter plate model for the formation of both Candida albicans and Candida auris biofilms and its application in high-throughput screening (HTS) techniques.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/978-1-0716-3155-3_5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Screening the Global Health Priority Box against Plasmodium berghei liver stage parasites using an inexpensive luciferase detection protocol.
Malar J
November 2024
Center for Tropical and Emerging Global Diseases, University of Georgia, 500 DW Brooks Dr, Athens, GA, 30602, USA.
Article Synopsis
- - Malaria, caused by the Plasmodium parasite, faces challenges due to drug resistance, prompting the need for new treatments targeting both symptomatic and asymptomatic liver stages; a cost-effective luciferase detection method for liver stage screening has been developed using common lab reagents.
- - The study optimized a protocol for testing liver stage parasites, validating it with 28 existing anti-malarials to ensure reliable signal data, enabling the screening of the Global Health Priority Box (GHPB) for potential drug candidates.
- - Results showed that the optimized screening method produced a more stable luciferase signal with lower cell density, identifying 9 promising hits with selective activity against the P. berghei liver stages.
A high-throughput microfluidic mechanoporation platform to enable intracellular delivery of cyclic peptides in cell-based assays.
Bioeng Transl Med
September 2023
Merck & Co., Inc. West Point Pennsylvania USA.
Cyclic peptides are poised to target historically difficult to drug intracellular protein-protein interactions, however, their general cell impermeability poses a challenge for characterizing function. Recent advances in microfluidics have enabled permeabilization of the cytoplasmic membrane by physical cell deformation (i.e.
View Article and Find Full Text PDFExperimental exposure assessment for cell-based bioassays in 96- and 384-well plates.
Front Toxicol
July 2023
Department of Cell Toxicology, Helmholtz Centre for Environmental Research-UFZ, Leipzig, Germany.
cell-based bioassays have great potential for applications in the human health risk assessment of chemicals. The quantification of freely dissolved concentrations ( ) in assays is essential to generate reliable data for -to- extrapolation. Existing methods for the quantification of are limited to low-throughput microtiter plates.
View Article and Find Full Text PDFDroplet microarray platforms for high-throughput drug screening.
Mikrochim Acta
June 2023
Biomedical Engineering, School of Medicine, The Chinese University of Hong Kong, Shenzhen, 518172, China.
High-throughput screening platforms are fundamental for the rapid and efficient processing of large amounts of experimental data. Parallelization and miniaturization of experiments are important for improving their cost-effectiveness. The development of miniaturized high-throughput screening platforms is essential in the fields of biotechnology, medicine, and pharmacology.
View Article and Find Full Text PDFUltra-High-Throughput and Low-Volume Analysis of Intact Proteins with LAP-MALDI MS.
J Am Soc Mass Spectrom
June 2023
Department of Chemistry, University of Reading, Whiteknights, Reading RG6 6DX, U.K.
High-throughput (HTP) mass spectrometry (MS) is a rapidly growing field, with many techniques evolving to accommodate ever increasing sample analysis rates. Many of these techniques, such as AEMS and IR-MALDESI MS, require volumes of at least 20-50 μL for analysis. Here, liquid atmospheric pressure-matrix-assisted laser desorption/ionization (LAP-MALDI) MS is presented as an alternative for ultra-high-throughput analysis of proteins requiring only femtomole quantities of protein in 0.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!